RxDoctor Payments Data

Ketaki Vaidhyanathan, MD

Psychiatry · Montclair, NJNPI 1992904445

Payments from drug & device makers

$3,429in general payments, 2019–2025

Across 228 payments — averaging $15.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$720
  • Otsuka America Pharmaceutical, Inc.$694
  • Teva Pharmaceuticals USA, Inc.$683
  • Johnson & Johnson$392
  • Neurocrine Biosciences, Inc.$280
  • Lundbeck LLC$192
  • plus $469 from 6 others

What the payments were for

  • Food & beverage$3,32597%
  • Education$1043%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,429 in reported general payments places this provider in the 85th percentile of 1,119 psychiatry providers in New Jersey.

See all psychiatry providers in New Jersey

Medicare billing

Part B allowed, 2024
$44,444
Medicare patients
87
Services billed
405

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate86$199,008
IngrezzaValbenazine Tosylate24$186,756
Abilify MaintenaAripiprazole25$65,762
AristadaAripiprazole Lauroxil21$53,940
VraylarCariprazine Hcl26$38,219
RexultiBrexpiprazole18$26,750
Aripiprazole199$23,784
Lurasidone Hcl51$18,281
Risperidone ErRisperidone Microspheres21$16,725
Chlorpromazine Hcl80$12,160
Clozapine OdtClozapine12$7,593
Paliperidone ErPaliperidone44$4,724
Clozapine77$4,508
Quetiapine Fumarate497$4,294
XanaxAlprazolam12$3,138

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$392$199,00886 claims
Neurocrine Biosciences, Inc.Ingrezza$280$186,75624 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$694$92,51243 claims
Alkermes, Inc.Aristada$720$53,94021 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,119 psychiatry providers in New Jersey.

Other psychiatry in Montclair

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →